Stocks
Fate Therapeutics (FATE) Operating Income US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -217.0 | -308.4 | -190.5 | -210.3 | -147.7 | -139.4 | |||
| Changes by years, y/y, % | +69% | +42% | -38% | +10% | -30% | +2.9% | |||
Fate Therapeutics. Operating Income, bln rub
Fate Therapeutics. Operating Income, changes, %
Fate Therapeutics. Operating Income, sum by quarters, bln rub
Fate Therapeutics (FATE) Operating Income US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Operating Income, bln rub | -41.3 | -37.0 | -34.7 | -34.7 | -33.0 | -139.4 | ||
| Changes by years, y/y, % | -19% | -18% | -34% | -44% | -20% | |||
| Changes by quarters, q/q, % | -33% | -10% | -6% | 0% | -5% | |||
